Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-20
2000-03-28
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 4, 514866, A61K 3828
Patent
active
060432144
ABSTRACT:
The present invention relates to a process for producing a therapeutic powder formulation, comprising (a) providing an acidic aqueous solution comprising an insulin or analoguc or derivative thereof and an enhancer; (b) adjusting the pH to a pH in the range of 4.5 to 7.4; (c) precipitating a product comprising the insulin or analogue or derivative thereof and the enhancer, wherein the precipitation is performed essentially without evaporation of the solution; and (d) removing the water.
REFERENCES:
patent: 5506203 (1996-04-01), Backstrom et al.
patent: 5747445 (1998-05-01), Backstrom et al.
Danielson et al. (1994) "New Routes and Means of Insulin Delivery", Childhood and Adolescent Diabetes, Chapman & Hall Medical pp. 571-584.
Niven (1995) "Delivery of Biotherapeutics by Inhalation Aerosol" Critical Reviews in Therapeutic Drug Carrier Systems 12(2&3) :151-231.
Sayani et al. (1996) "Systemic Delivery of Peptides and Proteins" Mucosae Critical Reviews in Therapeutic Drug Carrier Systems 13(1&2) : 85-184.
Hansen Philip
Jensen Steen
Lambiris, Esq. Elias J.
Novo Nordisk A S
Weddington Kevin E.
Zelson, Esq. Steven T.
LandOfFree
Method for producing powder formulation comprising an insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing powder formulation comprising an insulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing powder formulation comprising an insulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1326094